HORIZON Extension Trial of Ranibizumab (LUCENTIS®) for Neovascular Age-Related Macular Degeneration (AMD): Two-Year Safety and Efficacy Results

Essentials in Ophthalmology,2013, 引用: 1

Expert Review of Ophthalmology,2010, 引用: 0

Annals of Medicine,2012, 引用: 34

Journal of Ophthalmology,2012, 引用: 34

Graefes Archive for Clinical and Experimental Ophthalmology,2012, 引用: 20

Expert Opinion on Drug Safety,2010, 引用: 48

Ophthalmologica,2011, 引用: 12

Acta Ophthalmologica,2012, 引用: 20

,2015, 引用: 0